P2X3 receptor antagonist in chronic cough
We welcome the study of a P2X3 receptor antagonist in refractory chronic cough by Rayid Abdulqawi and colleagues (March 28, p 1198), considering the paucity of effective treatments for this disorder. However, the report raises three questions..
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2015 |
|---|---|
| Erschienen: |
2015 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:386 |
|---|---|
| Enthalten in: |
The lancet |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Bothamley, Graham H [VerfasserIn] |
|---|
| Links: |
|---|
| RVK: |
|---|
| doi: |
10.1016/S0140-6736(15)61274-0 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
OLC1969451149 |
|---|
| LEADER | 01000caa a2200265 4500 | ||
|---|---|---|---|
| 001 | OLC1969451149 | ||
| 003 | DE-627 | ||
| 005 | 20220223212447.0 | ||
| 007 | tu | ||
| 008 | 160211s2015 xx ||||| 00| ||eng c | ||
| 024 | 7 | |a 10.1016/S0140-6736(15)61274-0 |2 doi | |
| 028 | 5 | 2 | |a PQ20160211 |
| 035 | |a (DE-627)OLC1969451149 | ||
| 035 | |a (DE-599)GBVOLC1969451149 | ||
| 035 | |a (PRQ)c1861-d7fdc03e8369c6b11be88c8e5ddcfd903512d09a8466a25814023b8f1ae9c8ba0 | ||
| 035 | |a (KEY)0052227920150000386999000244p2x3receptorantagonistinchroniccough | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |q DNB |
| 084 | |a XA 10000 |q AVZ |2 rvk | ||
| 084 | |a 44.00 |2 bkl | ||
| 084 | |a 38.30 |2 bkl | ||
| 100 | 1 | |a Bothamley, Graham H |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a P2X3 receptor antagonist in chronic cough |
| 264 | 1 | |c 2015 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 520 | |a We welcome the study of a P2X3 receptor antagonist in refractory chronic cough by Rayid Abdulqawi and colleagues (March 28, p 1198), considering the paucity of effective treatments for this disorder. However, the report raises three questions. | ||
| 650 | 4 | |a Antitussive Agents - therapeutic use | |
| 650 | 4 | |a Cough - drug therapy | |
| 650 | 4 | |a Purinergic P2X Receptor Antagonists - therapeutic use | |
| 650 | 4 | |a Antagonist drugs | |
| 650 | 4 | |a Respiratory diseases | |
| 650 | 4 | |a Drug therapy | |
| 650 | 4 | |a Chronic obstructive pulmonary disease | |
| 700 | 1 | |a Turner, Richard D |4 oth | |
| 700 | 1 | |a Bhowmik, Angshu |4 oth | |
| 700 | 1 | |a Rajakulasingam, Raj K |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t The lancet <London> |d London [u.a.] : Elsevier, 1823 |g 386(2015), 9990, Seite 244 |w (DE-627)129080470 |w (DE-600)3306-6 |w (DE-576)014413191 |x 0140-6736 |7 nnns |
| 773 | 1 | 8 | |g volume:386 |g year:2015 |g number:9990 |g pages:244 |
| 856 | 4 | 1 | |u http://dx.doi.org/10.1016/S0140-6736(15)61274-0 |3 Volltext |
| 856 | 4 | 2 | |u http://www.ncbi.nlm.nih.gov/pubmed/26194521 |
| 856 | 4 | 2 | |u http://search.proquest.com/docview/1696909767 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_OLC | ||
| 912 | |a SSG-OPC-PHA | ||
| 912 | |a GBV_ILN_11 | ||
| 912 | |a GBV_ILN_21 | ||
| 912 | |a GBV_ILN_168 | ||
| 912 | |a GBV_ILN_183 | ||
| 912 | |a GBV_ILN_287 | ||
| 912 | |a GBV_ILN_2004 | ||
| 912 | |a GBV_ILN_2018 | ||
| 912 | |a GBV_ILN_2219 | ||
| 912 | |a GBV_ILN_2414 | ||
| 912 | |a GBV_ILN_4012 | ||
| 912 | |a GBV_ILN_4112 | ||
| 912 | |a GBV_ILN_4125 | ||
| 912 | |a GBV_ILN_4126 | ||
| 912 | |a GBV_ILN_4219 | ||
| 912 | |a GBV_ILN_4302 | ||
| 912 | |a GBV_ILN_4305 | ||
| 912 | |a GBV_ILN_4323 | ||
| 936 | r | v | |a XA 10000 |
| 936 | b | k | |a 44.00 |q AVZ |
| 936 | b | k | |a 38.30 |q AVZ |
| 951 | |a AR | ||
| 952 | |d 386 |j 2015 |e 9990 |h 244 | ||